Develops novel antibiotics to treat drug-resistant infections through advanced research.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Revagenix is a biopharmaceutical company that develops novel antibiotics and anti-infective therapies aimed at treating drug-resistant infections through advanced research and proprietary chemistry platforms. It focuses on building a pipeline of differentiated therapeutics by integrating drug discovery, development, and commercialization strategies to address critical gaps in infectious disease treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Revagenix Management Team
Investors
Novo Holdings
Revagenix Valuations & Financials
View real-time NPM data on Revagenix stock including daily Revagenix stock price estimates, valuation history, and historical share price information. Access Revagenix financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Revagenix pricing across six independent market signals. Looking for private company due diligence data sources on Revagenix? Get in touch to learn more.
Similar Companies
like Revagenix
Synfini
Healthcare & Life Sciences
Accelerates molecule discovery which combines neuro-symbolic AI and lab automation to streamline small-molecule drug development.
Segmed
Healthcare & Life Sciences
Real-world imaging datasets via a secure platform that enables rapid, scalable access to de-identified medical data for AI and research.
Conformal
Healthcare & Life Sciences
Focused on developing next-generation technology for left atrial appendage occlusion to reduce stroke risk.
Teon Therapeutics
Healthcare & Life Sciences
Reverses immune suppression in tumors by developing GPCR-targeted small molecules with combination immunotherapy potential.
Aardvark Therapeutics
Healthcare & Life Sciences
Developing oral therapies targeting gut-brain signaling to treat hunger-related disorders and metabolic diseases.
Mon Ami
Healthcare & Life Sciences
Simplifies human-services workflows by uniting client care, provider management and reporting into one solution.
CTRL Therapeutics
Healthcare & Life Sciences
Develops therapies which harness circulating tumor-reactive lymphocytes to treat solid cancers.
Accutar Biotech
Healthcare & Life Sciences
A biotechnology company that accelerates drug discovery using AI-powered computational design and wet lab validation.
Zuub
Healthcare & Life Sciences
Empowers dental practices with AI automation that simplifies insurance checks and streamlines treatment planning for clearer workflows.
FAQ
We have answers
Revagenix stock does not trade on public stock exchanges. Revagenix stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Revagenix stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Revagenix Stock does not trade on public stock exchanges. In order to sell Revagenix shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Revagenix does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Revagenix share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Revagenix stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Revagenix stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Revagenix stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Revagenix is a private company and has not had an IPO. There is currently no Revagenix IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Revagenix IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
